News

Insights Into Manhattan Associates' Earnings Performance

Insights Into Manhattan Associates' Earnings Performance

Understanding Manhattan Associates' Earnings Expectations

Manhattan Associates (NASDAQ: MANH) is preparing to unveil its quarterly earnings report soon. This update is highly anticipated by investors eager to understand the company's financial health and future prospects.

Analysts have high hopes, projecting an earnings per share (EPS) of $1.06 for the upcoming announcement. Investors are particularly interested in whether the company will exceed these expectations, which could potentially influence its stock price positively.

Guidance is an essential factor for investors, as it often determines whether a stock's price might rise or fall following an earnings report.

Reviewing Earnings History

In past earnings reports, Manhattan Associates surprised investors by beating EPS estimates, notably achieving an additional $0.22 in the last earnings announcement. As a result, the share price surged by 10.54% the following trading session. This history showcases the potential volatility and excitement around the company’s financial disclosures.

Let's examine the recent earnings results and their impact on the stock:

Performance Overview

The latest figures reveal an impressive upward trend in Manhattan Associates' performance:

  • In Q2 2024, EPS estimates were met with an actual of 1.18.
  • Q1 2024 showed strong performance as well, with an actual EPS of 1.03.
  • Price changes varied, with an encouraging 11.0% increase following Q2 results.

Current Stock Market Performance

As of mid-October, shares of Manhattan Associates are trading at approximately $298.28. Over the last year, the stock has witnessed a remarkable increase of 55.24%. Such robust growth suggests that long-term shareholders have a positive outlook as the earnings announcement approaches.

Insights from Analysts

Gaining insight into the market's sentiment is crucial for investors. Manhattan Associates holds a favorable opinion among analysts, receiving a consensus rating of Buy from five analysts. The average one-year price target stands at $286.4, subtly indicating a potential decrease from current levels, yet the overall sentiment remains strong.

Comparative Analysis with Peers

To better understand Manhattan Associates' standing, it’s useful to compare its performances with those of its peers, including Dynatrace, Guidewire Software, and Aspen Technology. Here are their current ratings and price targets:

  • Dynatrace: Outperform with a price target of $56.14; potential downside of 81.18%.
  • Guidewire Software: Outperform with a price target of $185.87; potential downside of 37.69%.
  • Aspen Technology: Buy with a price target of $246.75; indicating a potential downside of 17.28%.

Summary of Peer Performance

Manhattan Associates shows an exceptional performance, leading its peers in metrics such as Revenue Growth and Gross Profit. However, it lags in Return on Equity, which might be an area for investors to consider.

About the Company

Founded in 1990, Manhattan Associates specializes in providing software solutions for supply chain management, inventory control, and omnichannel operations. The company serves a diverse clientele, including retailers, manufacturers, and logistics providers, with over 1,200 customers worldwide.

Exploring Economic Impact

Market Capitalization Outcome: The market capitalization of Manhattan Associates currently reflects some constraints, possibly due to growth expectations and operational ability within the industry.

Revenue Growth Metrics: The company marked an impressive revenue growth rate of 14.85% in recent quarters, showcasing its ability to outperform many competitors in the technologically driven marketplace.

Profitability Analysis: With a significant net margin of 19.89%, Manhattan Associates exemplifies effective cost management and strong profitability relative to industry standards.

Return on Equity Insights: The company boasts a strong Return on Equity at 21.98%, effectively utilizing shareholder funds to generate profit.

Asset Utilization: Its Return on Assets at 7.88% signifies excellent operational efficiency, contributing to overall financial health.

Debt Control Strategies: The debt-to-equity ratio at 0.21 indicates prudent financial management, relying less on debt, which should appeal to cautious investors.

Frequently Asked Questions

What is the anticipated EPS for Manhattan Associates?

The expected earnings per share (EPS) is projected at $1.06 for the upcoming announcement.

How has Manhattan Associates performed in previous quarters?

The company has consistently exceeded EPS estimates, contributing to significant stock price increases following announcements.

What is the current stock price of Manhattan Associates?

The stock is trading at approximately $298.28, reflecting a notable rise of 55.24% over the past year.

What do analysts think about Manhattan Associates' future?

Analysts maintain a Buy recommendation, with a one-year price target of $286.4 suggesting a positive outlook despite minor corrections.

How does Manhattan Associates compare with its peers?

Manhattan Associates leads its peers in Revenue Growth and Gross Profit, though it ranks lower in Return on Equity relative to its industry competitors.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading

Top 5 Most Recently Viewed Articles

Celcuity Inc. Prepares for Third Quarter Financial Results

Updated Category News Views 91

Celcuity Inc. Announces Upcoming Financial Results Release Celcuity Inc. (NASDAQ: CELC), a pioneering biotechnology company focused on innovative oncology therapies, has exciting news. The company will be releasing its financial results for the third quarter of 2025 after the market closes. This significant event is scheduled for a Wednesday, with management set to...

Continue Reading
EverTrue and DonorSearch Team Up to Revolutionize Fundraising

Updated Category News Views 973

EverTrue's Strategic Acquisition of DonorSearch EverTrue, a leader in donor engagement and pipeline development, recently announced a significant acquisition. The company has acquired DonorSearch, known for its innovative AI-powered donor discovery solutions. This strategic move is aimed at enhancing the capabilities of fundraising teams, enabling them to connect with...

Continue Reading
Celebrating Creativity and Inclusion: ADCOLOR Awards 2025

Updated Category News Views 315

ADCOLOR Awards 2025: A Night of Inspiration and Celebration Presented by leading organizations in the industry like Amazon, Disney, and Meta, the ADCOLOR Awards is a prestigious event celebrating remarkable individuals and organizations that champion diversity and inclusion in creative fields. This year's ceremony showcased inspiring figures such as Richelieu Dennis,...

Continue Reading
Transforming a $1000 Investment in First Solar to $3700

Updated Category News Views 161

Transform Your Investment with First Solar First Solar (NASDAQ: FSLR) has shown impressive performance over the past decade. This company has not only managed to keep pace with the market but has actually outperformed it by an average of 2.49% annually. This impressive annualized return translates to an average annual growth of 14.22%, making First Solar a notable player...

Continue Reading
Carpenter Technology Announces New Quarterly Dividend Plans

Updated Category News Views 107

Carpenter Technology Announces Quarterly Cash Dividend Carpenter Technology Corporation (NYSE: CRS), a leading name in high-performance specialty alloys, has made a significant announcement regarding its quarterly cash dividend. The company's Board of Directors has declared a dividend of $0.20 per share on common stock, underscoring its commitment to returning value to...

Continue Reading